World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT03460080
Date of registration: 12/02/2018
Prospective Registration: No
Primary sponsor: Hanoi Medical University
Public title: Diagnostic Value of AFP-L3 and PIVKA-II in HCC
Scientific title: Diagnostic Value of AFP-L3 and PIVKA-II in HCC
Date of first enrolment: January 1, 2018
Target sample size: 200
Recruitment status: Unknown status
URL:  https://clinicaltrials.gov/show/NCT03460080
Study type:  Observational
Study design:   
Phase: 
Countries of recruitment
Vietnam
Contacts
Name:     Bui My Hanh, MD
Address: 
Telephone: +84983070973
Email: buimyhanh@hmu.edu.vn
Affiliation: 
Key inclusion & exclusion criteria

Inclusion Criteria:

- Age between 18 and 85

- Receiving no treatment before diagnosis

- Establishing Diagnosis according to thecriteria of Ministry of Public Health of
Vietnam 2012.

Exclusion Criteria:

- Clinical data missing

- Laboratory tests information missing

- Serum samples doesn't qualified

- Obstructive jaundice patients

- Medical history of taking warfarin



Age minimum: 18 Years
Age maximum: 85 Years
Gender: All
Health Condition(s) or Problem(s) studied
Hepatocellular Carcinoma
Intervention(s)
Diagnostic Test: AFP-L3 and PIVKA-II in HCC
Primary Outcome(s)
PIVKA-II [Time Frame: Day one]
Secondary Outcome(s)
Albumin [Time Frame: Day one]
Alpha-Fetoprotein (AFP) [Time Frame: Day one]
Antibodies to Hepatitis C virus (Anti HCV) [Time Frame: Day one]
Alpha-Fetoprotein-L3% (AFP-L3%) [Time Frame: Day one]
Hepatitis B virus surface antigen (HBsAg) [Time Frame: Day one]
Alanine Aminotransferase (ALT) [Time Frame: Day one]
Gamma Glutamyl Transferase (?-GT) [Time Frame: Day one]
Aspartate Aminotransferase (AST) [Time Frame: Day one]
Prothrombin Time (PT) (%) [Time Frame: Day one]
Secondary ID(s)
HMU16222
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Bach Mai Hospital
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history